全文获取类型
收费全文 | 151篇 |
免费 | 12篇 |
专业分类
林业 | 5篇 |
基础科学 | 1篇 |
7篇 | |
综合类 | 4篇 |
农作物 | 9篇 |
水产渔业 | 12篇 |
畜牧兽医 | 113篇 |
园艺 | 3篇 |
植物保护 | 9篇 |
出版年
2023年 | 1篇 |
2021年 | 3篇 |
2020年 | 9篇 |
2019年 | 4篇 |
2018年 | 4篇 |
2017年 | 5篇 |
2016年 | 4篇 |
2015年 | 2篇 |
2014年 | 3篇 |
2013年 | 8篇 |
2012年 | 8篇 |
2011年 | 7篇 |
2010年 | 8篇 |
2009年 | 8篇 |
2008年 | 11篇 |
2007年 | 8篇 |
2006年 | 11篇 |
2005年 | 10篇 |
2004年 | 8篇 |
2003年 | 8篇 |
2002年 | 6篇 |
2001年 | 1篇 |
2000年 | 4篇 |
1999年 | 4篇 |
1997年 | 1篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1984年 | 1篇 |
1980年 | 1篇 |
1976年 | 1篇 |
1973年 | 1篇 |
1971年 | 1篇 |
1940年 | 1篇 |
排序方式: 共有163条查询结果,搜索用时 15 毫秒
111.
Immunological aspects of mammary tumors in dogs and cats: a survey including own studies and pertinent literature 总被引:1,自引:0,他引:1
V P Rutten W Misdorp A Gauthier M Estrada J P Mialot A L Parodi G R Rutteman K Weyer 《Veterinary immunology and immunopathology》1990,26(3):211-225
Naturally occurring cancer in companion animals parallels cancer in man more closely than does experimentally induced cancer in inbred laboratory animals. In dogs and cats, as in man, a role for immune responses is indicated in the development of tumors. A survey is presented based on the literature and our own studies concerning the immunological and immunotherapeutic aspects of canine and feline mammary neoplasia. In dogs bearing mammary neoplasms, circulating immune complexes appear to play a negative role in the generation of effective antitumor immune responses. The functional role of peripheral blood lymphocytes and tumor-infiltrating lymphocytes in dogs and cats with mammary tumors is not yet fully established. No tumor antigen responsible for humoral or cellular responses has yet been identified. Extracorporeal perfusion of serum of dogs with mammary tumors and subcutaneous administration of mitomycin- and neuraminidase-treated autologous tumor cells are associated with improved prognosis. The opposite was true for i.v. treatment with BCG or Corynebacterium parvum vaccine in our study, in contrast to a previous report. A number of other treatment modalities in cats and dogs with mammary carcinomas failed to induce tumor regression. Canine and feline mammary carcinomas are good candidates for modern immunotherapeutic approaches. 相似文献
112.
Frost resistance of interspecific and varietal potato crosses was evaluated at Bogotá, Colombia using intact plants in a programmed low temperature growth cabinet. Plants were exposed to a 2 hour frost during the dark period and the minimum test temperature was successively lowered 1 C on subsequent nights. The foliage was visually scored for damage 10–12 hours after each frost. While most commercial varieties were killed at—2 to—3 C (28 to 26 F), 101 of 121 clones which have been bred specifically for frost resistance survived to at least—5 C (23 F) and some crosses resisted—9 C (16 F) without observable foliar damage. This suggests the possibility of obtaining cultivated varieties from varietal parents of cultivated species such as G. Andigena, G. Phureja, G. Stenotomum,S. ajanhuiri, and others, which are reasonably frost resistant. 相似文献
113.
114.
115.
116.
117.
118.
M.D.?SuárezEmail author M.?Abad T.?Ruiz-Cara J.D.?Estrada M.?García-Gallego 《Aquaculture International》2005,13(4):315-325
The changes in collagen content and its solubility in sea bream muscle were studied for variable storage times following the death of the fish, and these variables were related to the evolution of physical parameters important for consumer acceptance: firmness and water-holding capacity (WHC). The results show that the collagen content in muscle diminished slightly over storage time and that this variable was directly related to firmness but inversely related to the water-holding capacity. With regard to collagen solubility, a decline was detected in acid-soluble collagen (ASC) in the first few post mortem hours, perhaps related to the end of rigor mortis that occurs at these stages. Pepsin-soluble collagen (PSC) increased, while insoluble collagen (ISC) decreased from 96 h, coinciding with a loss of firmness. This softening can be explained as a result of specific collagenases acting on the insoluble fraction of the collagen. 相似文献
119.
Longitudinal Analysis of Quality of Life,Clinical, Radiographic,Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study 下载免费PDF全文
A. Boswood S.G. Gordon J. Häggström G. Wess R.L. Stepien M.A. Oyama B.W. Keene J. Bonagura K.A. MacDonald M. Patteson S. Smith P.R. Fox K. Sanderson R. Woolley V. Szatmári P. Menaut W.M. Church M.L. O'Sullivan J.‐P. Jaudon J.‐G. Kresken J. Rush K.A. Barrett S.L. Rosenthal A.B. Saunders I. Ljungvall M. Deinert E. Bomassi A.H. Estrada M.J. Fernandez Del Palacio N.S. Moise J.A. Abbott Y. Fujii A. Spier M.W. Luethy R.A. Santilli M. Uechi A. Tidholm C. Schummer P. Watson 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2018,32(1):72-85
Background
Changes in clinical variables associated with the administration of pimobendan to dogs with preclinical myxomatous mitral valve disease (MMVD ) and cardiomegaly have not been described.Objectives
To investigate the effect of pimobendan on clinical variables and the relationship between a change in heart size and the time to congestive heart failure (CHF ) or cardiac‐related death (CRD ) in dogs with MMVD and cardiomegaly. To determine whether pimobendan‐treated dogs differ from dogs receiving placebo at onset of CHF .Animals
Three hundred and fifty‐four dogs with MMVD and cardiomegaly.Materials and Methods
Prospective, blinded study with dogs randomized (ratio 1:1) to pimobendan (0.4–0.6 mg/kg/d) or placebo. Clinical, laboratory, and heart‐size variables in both groups were measured and compared at different time points (day 35 and onset of CHF ) and over the study duration. Relationships between short‐term changes in echocardiographic variables and time to CHF or CRD were explored.Results
At day 35, heart size had reduced in the pimobendan group: median change in (Δ) LVIDDN ?0.06 (IQR : ?0.15 to +0.02), P < 0.0001, and LA :Ao ?0.08 (IQR : ?0.23 to +0.03), P < 0.0001. Reduction in heart size was associated with increased time to CHF or CRD . Hazard ratio for a 0.1 increase in ΔLVIDDN was 1.26, P = 0.0003. Hazard ratio for a 0.1 increase in ΔLA :Ao was 1.14, P = 0.0002. At onset of CHF , groups were similar.Conclusions and Clinical Importance
Pimobendan treatment reduces heart size. Reduced heart size is associated with improved outcome. At the onset of CHF , dogs treated with pimobendan were indistinguishable from those receiving placebo.120.
Taneli Tirkkonen Jaakko Pakarinen Elina Rintala Terhi Ali-Vehmas Harri Marttila Olli AT Peltoniemi Johanna M?kinen 《Acta veterinaria Scandinavica》2010,52(1):21